InvestorsHub Logo
Followers 112
Posts 10856
Boards Moderated 0
Alias Born 03/01/2009

Re: Paullee post# 51

Tuesday, 03/03/2015 5:29:18 PM

Tuesday, March 03, 2015 5:29:18 PM

Post# of 64
No one here but us chickens...
and that's just the way I like it!
:)

I've been reading up on this one...
here's another tidbit to add to what you've posted

"Deerfield’s stake in French-based Flamel Technologies S.A. (ADR) (NASDAQ:FLML) remained unchanged over the quarter at 5.26 million shares worth $90.08 million. The stock of the biopharmaceutical company gained 20% in the last quarter of 2014, but since the beginning of the year it fell by 9%. During the fourth quarter, Flamel Technologies S.A. (ADR) (NASDAQ:FLML) has attracted more interest from investors as the number of funds holding the stock increased to 27 which held around $284.33 million worth of the company’s stock, versus 18 funds holding $223.26 million of stock in the previous quarter. Broadfin Capital is also a shareholder of Flamel Technologies S.A. (ADR) (NASDAQ:FLML), disclosing ownership of 5.15 million shares in its last 13F filing."
Read more at http://www.insidermonkey.com/blog/auspex-pharmaceuticals-inc-aspx-horizon-pharma-plc-hznp-deerfield-management-keeps-betting-on-pharmaceuticals-and-biotech-339694/2/#oJBldKX7rU7oEuov.99

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.